News | April 17, 2026
Moberg Pharma reports 2025 annual results, maintains strong cash position
The company reported net revenue of SEK 13.5 million for the full year 2025
The company reported net revenue of SEK 13.5 million for the full year 2025
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
Arcot is a seasoned executive with more than two decades of experience across the global pharma and life sciences sectors
Subscribe To Our Newsletter & Stay Updated
